References and Notes
1a
Evans BE.
Rittle KE.
Bock MG.
DiPardo RM.
Freidinger RM.
Whitter WL.
Lundell GF.
Veber
DF.
Anderson PS.
Chang RSL.
Lotti VJ.
Cerino DJ.
Chen TB.
Kling PJ.
Kunkel KA.
Springer JP.
Hirshfield J.
J. Med. Chem.
1988,
31:
2235
1b
Horton DA.
Bourne GT.
Smythe ML.
Chem. Rev.
2003,
103:
893
1c
Kumar A.
Maurya RA.
Ahmad P.
J.
Comb. Chem.
2009,
11:
198
2
Kale RR.
Prasad V.
Mohapatra P.
Tiwari VK.
Monatsh. Chemie
2010,
141:
1159
3
Lawrence RN.
Drug
Discovery Today
2000,
5:
172
4
Molnar A.
Boros S.
Simon K.
Hermecz I.
Gonczi C.
ARKIVOC
2010,
(x):
199
5a
Kim TH.
Lee N.
Lee G.
Kim JN.
Tetrahedron
2001,
57:
7137
5b
Gama Y.
Shibuya I.
Shimizu M.
Chem.
Pharm. Bull.
2002,
50:
1517
5c
Gama Y.
Shibuya I.
Shimizu M.
Goto M.
J. Carbohydr. Chem.
2001,
20:
459
5d
Alhede B.
Clamen FP.
Christensen J.
McCluskey KK.
Preikschat HF.
J. Org. Chem.
1991,
56:
2139
5e
Chern J.
Groziak MP.
Townsend LB.
J. Heterocycl. Chem.
1986,
23:
153
6
Mhaske SB.
Argade NP.
Tetrahedron
2006,
62:
9787
7a
Tiwari VK.
Singh DD.
Hussain HA.
Mishra BB.
Singh A.
Monatsh.
Chemie
2008,
139:
43
7b
Tiwari VK.
Hussain HA.
Mishra BB.
Singh DD.
Tripathi V.
Med. Chem. Res.
2007,
15:
325
7c
Tiwari VK.
Kale RR.
Mishra BB.
Singh A.
ARKIVOC
2008,
(xiv):
27
8a
Kale RR.
Prasad V.
Tiwari VK.
Tetrahedron Lett.
2010,
51:
5740
8b
Kale RR.
Prasad V.
Tiwari VK.
Lett. Org. Chem.
2010,
7:
136
8c
Tiwari VK.
Singh A.
Hussain HA.
Mishra BB.
Tripathi V.
Monatsh. Chem.
2007,
138:
1297
8d
Singh A.
Kale RR.
Tiwari VK.
Trends
Carbohydr. Res.
2009,
1:
80
9a
Pandey J.
Sharma A.
Tiwari VK.
Dube D.
Ramachandran R.
Chaturvedi V.
Sinha S.
Mishra NN.
Shulka PK.
Tripathi RP.
J. Comb. Chem.
2009,
11:
422
9b
Yu H.
Cheng J.
Ding L.
Khedri Z.
Chen Y.
Lau K.
Tiwari VK.
Chen Xi.
J.
Am. Chem. Soc.
2009,
131:
18467
9c
Tewari N.
Katiyar D.
Tiwari VK.
Tripathi RP.
Tetrahedron Lett.
2002,
44:
6639
9d
Tewari N.
Mishra RC.
Tiwari VK.
Tripathi RP.
Synlett
2002,
1779
9e
Tewari N.
Tiwari VK.
Mishra RC.
Tripathi RP.
Srivastava AK.
Ahmad R.
Srivastava R.
Srivastava BS.
Bioorg.
Med. Chem.
2003,
11:
2911
9f
Saxena N.
Verma SS.
Tiwari VK.
Chaturvedi V.
Manju YK.
Srivastva AK.
Gaikwad A.
Sinha S.
Tripathi RP.
Bioorg. Med. Chem.
Lett.
2006,
14:
8186
10
Typical Experimental
Procedure for the Synthesis of Quinazolinone-Fused Azauracil Compounds
3a-h
Diverse 2-thioxo-2,3-dihydroquinazolin-4
(1H)-ones 2a-h were obtained in good yield by the one-pot
reaction of anthranilic acid/esters, primary amines, and
bis(benzo-triazol-1-yl)methanethione in presence of the amidine
base as per ref. 7. Thioquinazolinone (2a,
0.5 g 1.96 mmol) was added in anhyd MeCN (8 mL) and stirred for
10 min then AgCNO (0.59 g, 3.93 mmol) was added in above solution. Solid
precipitated out within 5 min and reaction mixture was further stirred
for 30 min, where reaction mass turns into greenish color. Progress
of reaction was monitored by TLC (25% EtOAc in n-hexane). After completion of reaction, product
was filtered, dried, and subjected to column chromatography (25% EtOAc
in n-hexane) to obtain pure white solid
(90-95% yield).
Compound 3a:
yield 91%; mp 160-162 ˚C. IR
(KBr): νmax = 3429 (NH), 1676, 1591,
1568, 1508 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.04
(d, J = 7.5
Hz, 1 H), 7.83 (t, J = 7.2 Hz,
1 H), 7.71 (d, J = 8.4
Hz, 1 H), 7.43 (m, 4 H), 6.77 (m, 2 H). ¹³C
NMR (75 MHz, CDCl3): δ = 166.10,
161.03, 145.95, 139.88, 134.52, 129.39, 129.16, 128.14, 128.04, 126.49,
124.01, 119.64 ppm. Anal. Calcd for C16H10N4O3:
C, 62.74; H, 3.29; N, 18.29. Found: C, 62.51; H, 3.75; N, 18.88.
Compound 3b: yield 91%; mp 178-180 ˚C.
IR (KBr): νmax = 3431 (NH), 1669, 1596,
1569, 1511 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 11.02
(br s, 1 H, NH), 7.96 (d, J = 7.8
Hz, 2 H), 7.67 (t, J = 8.4
Hz, 2 H), 7.48 (d, J = 8.4
Hz, 1 H), 7.34 (t, J = 8.4
Hz, 1 H), 7.04 (t, J = 8.7
Hz, 2 H), 6.69 (s, 1 H). ¹³C NMR (75
MHz, CDCl3): δ = 167.84,
162.0, 140.91, 134.79, 134.79, 133.17, 133.06, 130.66, 129.96, 126.84, 123.90,
123.41, 118.27 ppm. Anal. Calcd for C19H11N5O3S: C,
58.61; H, 2.85; N, 17.99. Found: C, 58.22; H, 3.01; N, 18.45.
Compound 3c: yield 91%; mp 187-188 ˚C.
IR (KBr): νmax = 3430, 1677, 1593,
1577, 1507 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 9.82
(br s, NH, 1 H), 8.42 (d, J = 9.0
Hz, 2 H), 8.23 (m, 2 H), 7.77 (t, J = 7.8
Hz, 1 H), 7.48 (d, J = 8.7
Hz, 1 H), 7.38 (m, 1 H), 7.15 (d, J = 8.7
Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.5,
159.90, 145.33, 143.27, 137.98, 133.80, 129.00, 125.60, 124.35,
122.55, 122.42, 114.37, 114.17, 110.53 ppm.
Compound 3d: yield 91%; mp 171-173 ˚C.
IR (KBr): νmax = 3433 (NH), 1677 (O=CN),
1622, 1529 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 8.35
(d, J = 8.7
Hz, 2 H), 7.99-7.89 (m, merged with J = 7.2
Hz, 2 H), 7.75 (d, J = 8.4
Hz, 1 H), 7.49 (d, J = 8.1
Hz, 2 H), 7.33 (t, J = 7.5
Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.10,
159.07, 145.90, 139.54, 135.41, 130.72, 130.27, 130.17, 127.27,
126.27, 126.10, 124.39, 124.34 ppm. Anal. Calcd for C16H9FN4O3:
C, 59.26; H, 2.80; N, 17.28. Found: C, 59.93; H, 2.74; N, 17.97.
